Drug Discovery on Natural Products: From Ion Channels to nAChRs, from Nature to Libraries, from Analytics to Assays
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Rs in particular. The "Sources" part will discuss the relevance for drug discovery of finding bioactive compounds from various natural sources such as venoms and plant extracts. The "Approaches" part will give an overview of classical and new analytical approaches that are used for the identification of new bioactive compounds with the focus on targeting ion channels. In addition, a selected overview is given of traditional venom-based drug discovery approaches and of diverse hyphenated analytical systems used for screening complex bioactive mixtures including venoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for in vitro evaluating antimicrobial activity: A review
Balouiri, M., Sadiki, M., & Ibnsouda, S. K. (2016) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2015.11.005 · Cited by 8,044 · cited 1×
“With TLC, small quantities of complex mixtures can be separated while at the same time active compounds can be localized on the plate.(158,160,161) Moreover, BGF approaches traditionally use low-resolution fractionation (fraction sizes of minutes or milliliters) after LC separation of a mixture (snake venom, plant ext…”
BackgroundNMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Paoletti, P., Bellone, C., & Zhou, Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3504 · Cited by 2,523
Martin, C. R., Osadchiy, V., Kalani, A., & Mayer, E. A. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.04.003 · Cited by 1,284
Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System
Dani, J. A., & Bertrand, D. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105214 · Cited by 1,197 · cited 1×
“Typical characteristics of the α7-nAChR are its high desensitization rate, calcium permeability, and the relatively low affinity of acetylcholine and nicotine toward the receptor.(31,32) The most common functions awarded to the α7-nAChR are modulation of the other neurotransmitter systems, for example, modulation of s…”
BackgroundPhysiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022 · cited 1×
“The nAChRs can be divided into two groups: the muscletype nAChRs and the neuronal-type nAChRs.(13,14) The muscle-type nAChRs are found in neuromuscular junctions of the peripheral nervous system (PNS), whereas the neuronal types are found in the CNS, but are also expressed in non-neuronal tissues and organs, for examp…”
BackgroundBrain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678 · cited 1×
“In schizophrenia patients, the expression level of the α7nAChR is reduced in many brain regions compared with healthy subjects.(43,44) There have been several efforts for developing drugs targeting the α7-nAChR.”
BackgroundEffect of nicotine and nicotinic receptors on anxiety and depression
Picciotto, M. R., Brunzell, D. H., & Caldarone, B. J. (2002) · Neuroreport · doi:10.1097/00001756-200207020-00006 · Cited by 483 · cited 1×
“The abnormal functioning or loss of nAChRs has been associated with many CNS diseases, such as to Alzheimer’s disease,(36) Parkinson’s disease,(37) epilepsy,(38) schizophrenia,(39) attention deficit hyperactivity disorder (ADHD),(40) pain,(41) anxiety,(42) and depression.(42) In schizophrenia patients, the expression…”
BackgroundDesensitization of neuronal nicotinic receptors
Quick, M. W., & Lester, R. A. J. (2002) · Journal of Neurobiology · doi:10.1002/neu.10109 · Cited by 456
Nothias, L.-F., Nothias-Esposito, M., da Silva, R., Wang, M., Protsyuk, I., Zhang, Z., Sarvepalli, A., Leyssen, P., Touboul, D., Costa, J., et al. (2018) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00737 · Cited by 433
Kainate receptors coming of age: milestones of two decades of research
Contractor, A., Mulle, C., & Swanson, G. T. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2010.12.002 · Cited by 292
Tribollet, E., Bertrand, D., Marguerat, A., & Raggenbass, M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.09.028 · Cited by 199
Wilens, T. E., & Decker, M. W. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.002 · Cited by 164
Kim, D. S., Choi, H.-I., Wang, Y., Luo, Y., Hoffer, B. J., & Greig, N. H. (2017) · Cell Transplantation · doi:10.1177/0963689717721234 · Cited by 136
Melani, R. D., Skinner, O. S., Fornelli, L., Domont, G. B., Compton, P. D., & Kelleher, N. L. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.056523 · Cited by 85 · cited 1×
“relevant noncovalent protein–protein and protein–ligand interactions, and database quality.(201) One of the challenges in these approaches is considering posttranslational modifications (PTMs), such as amidations (e.”
BackgroundKool, J., Heus, F., de Kloe, G., Lingeman, H., Smit, A. B., Leurs, R., Edink, E., De Esch, I. J. P., Irth, H., & Niessen, W. M. A. (2011) · SLAS Discovery · doi:10.1177/1087057111413921 · Cited by 21 · cited 1×
“Nonradioactive binding assays developed for screening α7nAChR and 5-HT3R ligands include SPR-based AChBP ligand binding assays,(138) TIRF assays for studying the 5-HT3R, 128,129 and fluorescence enhancement assays using AChBP as a soluble binding protein that mimics the extracellular domain of the α7-nAChR.(130,139) F…”
MethodSelf-citation
Cited by
Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety
Shaito, A., Thuan, D. T. B., Phu, H. T., Nguyen, T. H. D., Hasan, H., Halabi, S., Abdelhady, S., Nasrallah, G. K., Eid, A. H., & Pintus, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00422 · Cited by 437
Ho, T. N. T., Abraham, N., & Lewis, R. J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.609005 · Cited by 87
Hassan, I., Wan Ibrahim, W. N., Yusuf, F. M., Ahmad, S. A., & Ahmad, S. (2020) · Journal of Toxicology · doi:10.1155/2020/8815313 · Cited by 15
Spirulina and Herbal Combination on Metabolic Alterations of Cardiovascular Diseases (CVDs)
Pandey, R., & Singh, S. (2022) · International Journal of Research and Review · doi:10.52403/ijrr.20220334 · Cited by 6
Metadata
- Authors
- Otvos, R. A., Still, K. B. M., Somsen, G. W., Smit, A. B., & Kool, J.
- Venue
- SLAS Discovery
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 24
- Issue
- 3
- Pages
- 362-385
- ISSN
- 2472-5552 (ISSN-L)
- OpenAlex
- W2912187298
- Cited by
- 39
- References
- 16
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.